Hoyer D, Schoeffter P
Preclinical Research, SANDOZ Pharma Ltd, Basel, Switzerland.
J Recept Res. 1991;11(1-4):197-214. doi: 10.3109/10799899109066399.
Our knowledge about 5-HT (serotonin, 5-hydroxytryptamine) receptors has gained significantly over the recent few years. The discovery of selective ligands and the use of new techniques have led to a significant increase in the number of recognised receptors subtypes. The present status of awareness is largely related to the use of radioligand binding studies, autoradiography, second messenger analysis and more recently, molecular biological techniques. Three main families of 5-HT receptors, of which subtypes have been described, are now accepted. This heterogeneity is further substantiated by the cloning of the cDNA's of three different 5-HT receptors. This article reviews some of the recent developments which led to the characterisation of 5-HT receptor subtypes.
近年来,我们对5-羟色胺(血清素,5-羟色胺)受体的了解有了显著增加。选择性配体的发现和新技术的应用使得已识别的受体亚型数量大幅增加。目前的认知状况很大程度上与放射性配体结合研究、放射自显影、第二信使分析以及最近的分子生物学技术的应用有关。现已公认存在三大类5-羟色胺受体,其中各亚型已被描述。三种不同5-羟色胺受体的cDNA克隆进一步证实了这种异质性。本文综述了一些导致5-羟色胺受体亚型得以鉴定的最新进展。